Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
2
×
chronic migraine
2
×
clinical trials
eli lilly
fda
2
×
indiana blog main
indiana top stories
life sciences
migraine research foundation
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
alder biopharmaceuticals
alprazolam
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cgrp inhibitors
colucid pharmaceuticals
david rind
detroit blog main
detroit top stories
drug enforcement administration
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
indiana
institute for clinical and economic review
lasmiditan
migraines
national
national top stories
new york blog main
What
approval
2
×
drug
fda
migraine
new
won
acute
addresses
amgen
candidates
causes
class
condition
decades
developed
eli
friday
gets
giant
giving
head
lasmiditan
lilly
lilly’s
medication
medicines
nod
oks
pain
pharmaceutical
preventive
second
starts
Language
unset
Current search:
approval
×
" boston blog main "
×
fda
×
" chronic migraine "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
